Sutro Biopharma's Series E Round

Sutro Biopharma raised a round of funding on June 06, 2018.

Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on leveraging its integrated cell-free protein synthesis platform, XpressCF, to create a broad variety…

Articles about Sutro Biopharma's Series E Round: